99 related articles for article (PubMed ID: 10215212)
1. Hematologic evaluation of cardiopulmonary bypass circuits prepared with a novel block copolymer.
Rubens FD; Labow RS; Lavallée GR; Watson MI; Robblee JA; Voorhees ME; Nathan HJ
Ann Thorac Surg; 1999 Mar; 67(3):689-96; discussion 696-8. PubMed ID: 10215212
[TBL] [Abstract][Full Text] [Related]
2. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
4. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
5. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
[TBL] [Abstract][Full Text] [Related]
6. Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss.
Wagner WR; Johnson PC; Thompson KA; Marrone GC
Ann Thorac Surg; 1994 Sep; 58(3):734-40; discussion 741. PubMed ID: 7944696
[TBL] [Abstract][Full Text] [Related]
7. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
[TBL] [Abstract][Full Text] [Related]
8. Autotransfusion in coronary artery bypass grafting: disparity in laboratory tests and clinical performance.
Flom-Halvorsen HI; Ovrum E; Tangen G; Brosstad F; Ringdal MA; Oystese R
J Thorac Cardiovasc Surg; 1999 Oct; 118(4):610-7. PubMed ID: 10504624
[TBL] [Abstract][Full Text] [Related]
9. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model.
Bannan S; Danby A; Cowan D; Ashraf S; Gesinde M; Martin P
Eur J Cardiothorac Surg; 1997 Aug; 12(2):268-75. PubMed ID: 9288518
[TBL] [Abstract][Full Text] [Related]
10. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
[TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
12. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
Nakajima H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
[TBL] [Abstract][Full Text] [Related]
15. Poly-2-methoxyethylacrylate-coated bypass circuits reduce activation of coagulation system and inflammatory response in congenital cardiac surgery.
Suzuki Y; Daitoku K; Minakawa M; Fukui K; Fukuda I
J Artif Organs; 2008; 11(3):111-6. PubMed ID: 18836870
[TBL] [Abstract][Full Text] [Related]
16. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.
Wippermann J; Albes JM; Hartrumpf M; Kaluza M; Vollandt R; Bruhin R; Wahlers T
Eur J Cardiothorac Surg; 2005 Jul; 28(1):127-32. PubMed ID: 15939621
[TBL] [Abstract][Full Text] [Related]
17. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass.
De Somer F; Van Belleghem Y; Caes F; François K; Van Overbeke H; Arnout J; Taeymans Y; Van Nooten G
J Thorac Cardiovasc Surg; 2002 May; 123(5):951-8. PubMed ID: 12019381
[TBL] [Abstract][Full Text] [Related]
19. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation and aggregation during normothermic cardiopulmonary bypass.
Misawa Y; Konishi H; Kawahito K; Fuse K
Jpn J Thorac Cardiovasc Surg; 2001 Jan; 49(1):21-8. PubMed ID: 11233238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]